US-based GRIP Molecular Technologies develops in-house diagnostic test that is based on a single-use bio-sensor. The sensor contains CVD graphene.
GRIP Molecular raised $3 million in 2021 and is on track for a commercial launch in 2025.
1000 Westgate Drive
Saint Paul, MN 55114
United States